Zepbound Tirzepatide Prescribing Information
Tirzepatide is a GIP and GLP-1 receptor agonist administered by subcutaneous injection with dose escalation and safety warnings including thyroid C-cell tumor risk.
Source →Therapy Hub
Weight Management
Weight Management includes injectable incretin therapies and oral weight-loss protocols used as part of prescriber-directed care with nutrition, activity, contraindication screening, and ongoing monitoring.
Product Search
Prescriber Product Search
Start typing a medication name to see available Genesis product pages, formats, routes, and therapy hubs.
Available Medications
Medications and product segments have been placed into this hub based on their primary clinical purpose, route, and supporting evidence.
GLP-1 Semaglutide 10mg (10mg/1mL)
Semaglutide is a GLP-1 receptor agonist used in diabetes and chronic weight-management contexts under prescriber direction.
GLP-1 Semaglutide 30mg (10mg/1mL)
Semaglutide is a GLP-1 receptor agonist used in diabetes and chronic weight-management contexts under prescriber direction.
GLP-1 Semaglutide 40mg (20mg/1mL)
Semaglutide is a GLP-1 receptor agonist used in diabetes and chronic weight-management contexts under prescriber direction.
GLP-1 Semaglutide 60mg (20mg/1mL)
Semaglutide is a GLP-1 receptor agonist used in diabetes and chronic weight-management contexts under prescriber direction.
GLP-1 Tirzepatide & B6 10mg (10mg/1mL)
Tirzepatide is a GIP and GLP-1 receptor agonist used in diabetes and chronic weight-management contexts under prescriber direction.
GLP-1 Tirzepatide & B6 30mg (10mg/1mL)
Tirzepatide is a GIP and GLP-1 receptor agonist used in diabetes and chronic weight-management contexts under prescriber direction.
GLP-1 Tirzepatide & B6 40mg (20mg/1mL)
Tirzepatide is a GIP and GLP-1 receptor agonist used in diabetes and chronic weight-management contexts under prescriber direction.
GLP-1 Tirzepatide & B6 60mg (20mg/mL)
Tirzepatide is a GIP and GLP-1 receptor agonist used in diabetes and chronic weight-management contexts under prescriber direction.
Naltrexone 4.5mg
Naltrexone is an opioid receptor antagonist used for alcohol/opioid-use disorder and some low-dose/off-label protocols.
Naltrexone 4.5mg (can split in 1/2 or 1/4 for titration)
Naltrexone is an opioid receptor antagonist used for alcohol/opioid-use disorder and some low-dose/off-label protocols.
Orforglipron + B6 12mg
Orforglipron is an investigational oral non-peptide GLP-1 receptor agonist described in clinical studies.
Orforglipron + B6 24mg
Orforglipron is an investigational oral non-peptide GLP-1 receptor agonist described in clinical studies.
Orforglipron + B6 3mg
Orforglipron is an investigational oral non-peptide GLP-1 receptor agonist described in clinical studies.
Orforglipron + B6 1mg
Orforglipron is an investigational oral non-peptide GLP-1 receptor agonist described in clinical studies.
Orforglipron + B6 36mg
Orforglipron is an investigational oral non-peptide GLP-1 receptor agonist described in clinical studies.
Oxytocin 50iu | PT-141 1mg | Tadalafil 5mg
Tadalafil is a phosphodiesterase-5 inhibitor used for erectile dysfunction and other prescriber-directed protocols.
Phentermine 20mg | Bupropion 65mg | Methylcobalamin 1mg | Naltrexone 8mg | Topiramate 15mg
Methylcobalamin is an active form of vitamin B12.
Phentermine 37.5mg | Topiramate 25mg
Phentermine is a sympathomimetic anorectic used short-term for weight management in selected patients.
Semaglutide 0.5mg
Semaglutide is a GLP-1 receptor agonist used in diabetes and chronic weight-management contexts under prescriber direction.
Semaglutide 1mg
Semaglutide is a GLP-1 receptor agonist used in diabetes and chronic weight-management contexts under prescriber direction.
Semaglutide 1mg/mL
Semaglutide is a GLP-1 receptor agonist used in diabetes and chronic weight-management contexts under prescriber direction.
Semaglutide Pill
Semaglutide is a GLP-1 receptor agonist used in diabetes and chronic weight-management contexts under prescriber direction.
Tirzepatide 3mg
Tirzepatide is a GIP and GLP-1 receptor agonist used in diabetes and chronic weight-management contexts under prescriber direction.
Tirzepatide 5mg
Tirzepatide is a GIP and GLP-1 receptor agonist used in diabetes and chronic weight-management contexts under prescriber direction.
Tirzepatide 7.5mg
Tirzepatide is a GIP and GLP-1 receptor agonist used in diabetes and chronic weight-management contexts under prescriber direction.
Topiramate 15mg | Bupropion 100mg | Naltrexone 10mg
Topiramate is an antiepileptic medication also used in migraine prevention and weight-management combinations.
More Medications Available
Prescription-only compounded preparation for prescriber-directed therapy.
References
Studies, data, and supporting evidence
These sources support the conservative educational statements on this page. They do not replace individualized medical judgment.
Wegovy Semaglutide Prescribing Information
Semaglutide is a GLP-1 receptor agonist that activates GLP-1 receptors involved in appetite regulation and caloric intake.
Source →Endocrine Society Pharmacological Management of Obesity
Recommends diet, exercise, and behavioral modification as part of all obesity management approaches, with medications used when patients meet label criteria.
Source →